ARCHIVES

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

This article is from The Cancer Letter archive.

Vol. 31 No. 13 | April 1, 2005

Download PDF Visit The Full Archive

Related Articles

Dana-Farber And Merck To Collaborate On Therapeutics.

February 15, 2008

In Brief: Mauer to Leave St. Jude For U. Tennessee As Cancer Program Director; Harvard, MIT Share ACS Award

July 29, 1983

NCI Cooperative Group, Cancer Center Trials Listed

January 25, 2008

In Brief: Robert Bast Succeeds Singleton As Director Of Duke Cancer Center; Robert Bell Deputy

August 14, 1987

In Brief: Bailes Elected President Of ASCO For 1999; Outlines Goals In Remarks To ACCC

March 20, 1998

Report Urges Better Working Conditions For Postdocs.

October 6, 2000